BIOMAT Database Logo BIOMAT Database Logo

Interpretation of results obtained using digoxin radioimmunoassay. 1974

S Lader, and B Johnson

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

S Lader, and B Johnson
Spurious results of digoxin radioimmunoassay.
March 1984, The New England journal of medicine,
S Lader, and B Johnson
Digoxin radioimmunoassay.
January 1971, Lancet (London, England),
S Lader, and B Johnson
[Interpretation of results obtained from multivariate analyses using plotting programs].
January 1968, Elektro Medizin; Biomedizin und Technik,
S Lader, and B Johnson
Radioimmunoassay of digoxin.
January 1972, Lancet (London, England),
S Lader, and B Johnson
Insulin radioimmunoassay: inappropriately high results obtained using a preprecipitated antibody technique.
February 1980, Clinica chimica acta; international journal of clinical chemistry,
S Lader, and B Johnson
Radioimmunoassay of digoxin: an intercomparison of results with three methods.
September 1973, Clinical chemistry,
S Lader, and B Johnson
Some factors affecting a commercial kit for radioimmunoassay of digoxin using tritiated digoxin.
May 1977, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie,
S Lader, and B Johnson
Interpretation of results obtained by activation analysis.
December 1969, Journal - Forensic Science Society,
S Lader, and B Johnson
Interpretation of experimental results obtained with dibenamine.
March 1949, Endocrinology,
S Lader, and B Johnson
[Radioimmunoassay of serum digoxin by 125I digoxin-kit].
January 1977, Horumon to rinsho. Clinical endocrinology,
Copied contents to your clipboard!